Division of Epidemiology

New analytical approach identifies novel risk genes for colorectal cancer

The study advances understanding of risk for colon and rectal cancers and points to targets for developing new treatments.

Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study

The retrospective study analyzed the electronic health records of 1,257 patients ages 18 to 65 who underwent bariatric surgery at Vanderbilt Health from 2017 to 2022, and 1,809 patients treated with the drugs semaglutide or tirzepatide from 2018 to 2023. 

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

VIGH’s Douglas Heimburger retires

He helped create research training opportunities for doctoral and postdoctoral trainees at Vanderbilt as well as those from low- and middle-income countries.

New NCI-funded project targets polyp recurrence to prevent colon cancer

The researchers anticipate that their findings will inform personalized colorectal polyp surveillance, guide therapeutic prevention strategies, and ultimately reduce the burden of colorectal cancer nationwide.

(Shutterstock)

Keloid risk genes open door to better therapy

These raised scars tend to recur after surgical removal, and the effectiveness of alternative treatments is limited.

1 2 3 10